Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sen

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Cancer Discovery|January 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody TarlatamabAvanish Mishra, Catherine B Meador, Kruthika Kikkeri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2024
OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image SegmentationA D Constantinou, A Hoole, D C Wong, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|September 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral controlSarah A Weiss, Amy Y Huang, Megan E Fung, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|July 27, 2021
Differentiation of exhausted CD8<sup>+</sup> T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memoryPierre Tonnerre, David Wolski, Sonu Subudhi, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Cancer Immunology Research|September 21, 2021
Supporting the Next Generation of Scientists to Lead Cancer Immunology ResearchElise Alspach, Ryan D Chow, Shadmehr Demehri, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Cancer Discovery|January 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody TarlatamabAvanish Mishra, Catherine B Meador, Kruthika Kikkeri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 10, 2024
OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image SegmentationA D Constantinou, A Hoole, D C Wong, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|September 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral controlSarah A Weiss, Amy Y Huang, Megan E Fung, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|July 27, 2021
Differentiation of exhausted CD8<sup>+</sup> T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memoryPierre Tonnerre, David Wolski, Sonu Subudhi, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Cancer Immunology Research|September 21, 2021
Supporting the Next Generation of Scientists to Lead Cancer Immunology ResearchElise Alspach, Ryan D Chow, Shadmehr Demehri, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Pageof 28